Regentys

[Regentys @Regentys1]

Generex Biotechnology Subsidiary Regentys Corporation Receives Approval of Japanese Patent for Extracellular Matrix Hydrogel (Regentys ECMH™)

https://t.co/FVuEUveKd0

[Regentys @Regentys1]

Generex Biotechnology Completes Acquisition of Regentys Corporation

Generex Biotechnology Corporation (OTC: GNBT) is pleased to announce that the company has completed the acquisition of 51% of Regentys™ Corporation, a regenerative medicine company.

https://t.co/tTrY22jhzd

[Regentys @Regentys1]

Generex Biotechnology Partner Regentys Corporation Receives European Patent Approval for ECMH™ for Treatment of Ulcerative Colitis

#regentys #ulcerativecolitis #crohnsdisease #mcgowaninstitute #generex

https://t.co/x58ubfp7rq

[Regentys @Regentys1]

Former 43North winner receives $15 million investment

The Company announced last week that it would accept a $15 million investment from publicly traded Generex Biotechnology Corp. in return for 51 percent of the Company.

https://t.co/RZiAjmbEsW

[Regentys @Regentys1]

What to Do When the Doctors Don’t Know How to Help #Regentys

Differential diagnosis, misdiagnosis, and even not receiving a diagnosis can be major problems for patients suffering through issues that are hard to explain to those who don’t understand...

https://t.co/OnztyR0Bfi

[Regentys @Regentys1]

Traveling When You Have Crohn’s Disease and IBD #regentys

https://t.co/DWyOfzP5rH

[Regentys @Regentys1]

Congratulations Marc & Regentys!!

#Regentys #ulcerativecolitis #regenerativemedicine #ECMH #Lyfebulb

[Regentys @Regentys1]

Finalists Announced for UnitedHealth and Lyfebulb’s IBD-related Innovation Challenge

...and Regentys is one of them!!

https://t.co/2WzNfRZevS

[Regentys @Regentys1]

Regentys Named as a Finalist in the Lyfebulb and UnitedHealth Group 2018 Innovation Challenge for Patient Entrepreneurs #regentys

https://t.co/M03tXFbJrr

[Regentys @Regentys1]

Types of Rectal Bleeding with Crohn’s Disease and IBD #regentys

https://t.co/b1UEFG4kOj

[Regentys @Regentys1]

Suffering from inflammatory bowel disease can put you at higher risk of heart attacks #regentys1

https://t.co/WFqeIiQnhc

[Regentys @Regentys1]

Crohn’s and Colitis Foundation Updates Research Network, Now Called IBD Partners #regentys

https://t.co/SCwLJYUaJS

[Regentys @Regentys1]

Regentys and Cook Partnering on Ongoing Development of Ulcerative Colitis Therapy #regentys

https://t.co/WldfwRWwl8

[Regentys @Regentys1]

The Reality of Bowel Surgery for Ulcerative Colitis #regentys

https://t.co/jfru2n1SgP

[Regentys @Regentys1]

Regentys, Cook Biotech to Collaborate in Developing, Delivering Unique Ulcerative Colitis Treatment #regentys

https://t.co/4AWZ4Ckkto

[Regentys @Regentys1]

U.S. Survey Sheds Light on How Ulcerative Colitis Affects Patients’ Lives #regentys

Sixty-four percent said the disease controlled their lives, with 63 percent saying they were spending an inordinate amount of time in the bathroom.

https://t.co/1EP3BWVVhT

[Regentys @Regentys1]

Patients with Crohn’s Disease Often Misdiagnosed for Ulcerative Colitis #regentys

Crohn’s disease is a chronic inflammatory bowel disease of the digestive or GI tract.

https://t.co/hpZemguJsu

[Regentys @Regentys1]

Regentys Names Dr. John F. Howes Vice President of Clinical and Regulatory Affairs #Regentys

https://t.co/zkjojYYYYe

[Regentys @Regentys1]

Living With Ulcerative Colitis While at College #Regentys1

"Find good people who will support you and be there for you when you need them."

https://t.co/SjcWCzgYOY

[Regentys @Regentys1]

A Crohn’s Story: ‘Pun Intended’ #regentys1

https://t.co/dt0VmImRzh